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1. Introduction 
Oyer the past few years evidence has accumulated 
that protein phosphatase-I is of central importance in 
the regulation of glycogen metabolism in mammalian 
skeletal muscle. This enzyme catalyses the dephos- 
phorylation of glycogen phosphorylase, phosphorylase 
kinase and glycogen synthase, and therefore carries 
out the reactions which inhibit glycogenolysls or 
activate glycogen synthesis (reviewed [ 1,2]). 
Protein phosphatase-I has been shown to be 
inhibited in vitro by two heat-stable proteins termed 
inhibitor-l and in~~ibitor-2, one of which (inhibitor-l) 
is only an inhibitor after it has been phosphorylated 
by cyclic AMP-dependent protein kinase [3,4]. 
Inhibitor-l and inhibitor-2 have been purified to 
homogeneity in this laboratory [5,6] and characterized’ 
extensively [ 1,7-93. Inhibitor-l is phospho~lated 
by cyclic AMP-dependent protein kinase in vitro at a 
similar rate to phosphorylase kinase and glycogen 
synthase 171. It inhibits the phosphorylase phosphatase, 
phosphorylase kinase phosphatase and glycogen 
synthase phosphatase activities of protein phospha- 
tase-I in a reversible non-competitive manner,and half- 
maximal inhibition is observed at 3-4 nM [S]. The 
concentration of ~nhibitor”l in rabbit skeletal muscle 
is 1.8 PM 161, which is higher than the concentration 
of protein phosphatase-1 [11. 
The properties of inhibitor-l determined in vitro 
are consistent with the idea that this protein is impor- 
tant in the regulation of protein phosphatase-1 in vivo. 
It has been demonstrated that inhibitor-l is phos- 
phorylated in rabbit skeletal muscle in vivo, and that 
its degree of phosphorylation increases markedly in 
response to adrenaline [IO]. Here we demonstrate 
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that insulin decreases the phosphorylation of inhibitor-l 
in rat skeletal muscle. The implications of this finding 
for the control of glycogen ~letabollsrn and mecha- 
nism of action of insulin are discussed. 
2. Methods 
Male rats of the Sprague-Dawley strain (Charles 
River Breeding Labs.) were maintained on Purina Lab. 
chow and water ad libitum. Rats of 200-300 g were 
hcparinized (10 nlg~kg) and anaesthetized with Nem- 
butal (50 mg/kg) in preparation for hemicorpus per- 
fusion [ 1 I]. The perfusion medium consisted of 
Krebs-Henseleit bicarbonate buffer containing 3% (w/v) 
bovine serum albuln~ (Miles, fraction V) and 30% 
(v/v) washed bovine erytllrocytes. The perfusate was 
gassed with humidified 02-CO2 (95 : 5) and main- 
tained at 37°C. Following an initial 50 ml washout, 
100 ml perfusate were recirculated at 14 ml/min flow- 
rate. After 60 min perfusion, the medium was 
supplemented with isoproterenol(1 X I Oe7 M), 
insulin (3.3 X 1 O-’ M), isoproterenol plus insulin, or 
saline (control).,Tissue samples were obtained 25 min 
after the additions by rapidly freezing a portion of 
hind-limb muscle (3-4 g) in clamps cooled in liquid 
nitrogen. Frozen muscle was prepared for analysis by 
pulverisation in a percussion instrument at liquid 
nitrogen temperature and stored at -70°C. 
2.2. State of ~~~sp~~~~~~~~~~ of inhibitur-f 
The frozen muscle powders were extracted with 
4 vof. 1.5% trichloroacetic acid-4 mM EDTA and 
centrifuged for 45 min at 6000 X g. The s~lpernatants 
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were decanted and treated with 100% trichloroacetic 
acid to give 1.5% (w/v) final cone, After standing at 
4°C for 3 h, the suspensions were centrifuged at 
20 000 X g for 10 min. The precipitates were resus- 
pended in 0.5 M Tris-WC1 (pH X -0) titrated to pH 7.4 
with arnrnolliurll hydroxide, and the volume was 
adjusted to 217th of the original weight of the tissue. 
The solutions were lyophilized and stored at -20°C 
until analysis. 
The lyophilized powders were taken up in water, 
dialysed against 5 mM Tris-HCl (pH 7.0) and heated 
for 5 min at 1OO’C. The suspensions were cooled to 
O”C, centrifuged for 2 min at 10 000 X g and the 
supernatants lyophilized. The freeze dried material 
was redissolved in 0.1 ml water and the state of phos- 
phorylation of inhibitor-l was then measured as in [lo]. 
3. Results 
It has been shown in [lo] that inhibitor-l is not 
precipitated or inactivated when rabbit skeletal muscle 
is homogenized with 1.5% trichloroacetic acid. The 
same result was obtained here using rat skeletal muscle. 
Extraction of the tissue in this manner is therefore a 
very effective method of destroying the interconvert- 
ing enzymes which would otherwise alter the state of 
phosphorylation of inhibitor-l. 
The percentage phosphorylation of inhibitor-1 was 
determined by making the following three measure- 
ments: 
(i) Inhibitor activity was measured without any pre- 
treatment; 
(ii) The total in~libitor activity was measured after 
~~~axirnal pllosphorylation by the catalytic sub- 
unit of cyclic AMP-dependent protein kinase; 
(iii) The inhibitor activity was measured after maxi- 
mal dephosphorylation by protein phosphatase-I .
As described for rabbit skeletal muscle, the inhibitor 
activity was completely destroyed by illcubatio~l with 
protein phosphatase, since inhibitor-2 is eliminated 
during the initial centrifugation of the 1.5% trichloro- 
acetic acid homogenate ] lo]. 
The results of the experinlents carried out with the 
perfused hind-limb system are summarized in table 1, 
In the absence of both insulin and adrenaline, the phos- 
phoryhtion of inhibitor-l averaged 52 -t 12%. The 
degree of phosphorylation was reduced to 28 rt 11% 
when insulin was included in the perfusate, The 
P-adrenergic agonist isoproterenol raised the phos- 
phorylation to 73 +_ 1 l%, and this hormone effectively 
blocked the reduction in phosphorylation that 
occurred in response to insulin. 
4. Discussion 
These results demonstrated that physiological con- 
centrations of insulin lower the state of phosphoryla- 
tion and the activity of inhibitor-l in rat skeletal 
muscle in viva. Substantial decreases in the activity of 
inhibitor-l were recorded in every experiment (table I). 
The results suggest hat the dephosphorylation of 
Table I 
Influence of insulin and isoproterenal on the state of phosphorylation of 
inhibitor-l in rat skeletal muscle 
--~- 
Expt Control 
--~-.l___l 
Phosphorylation of inhibitor-l [%) 
Insulin Insulin + isoproterenol Isoproterenol 
1 56 17 55 73 
2 66 33 56 71 
3 60 20 64 89 
4 - 29 - 80 
5 65 49 71 72 
6 43 36 54 55 
7 40 26 - 
8 36 17 
AY. (+SD) 52 f. 12 28‘111 60”7 73111 
Experiments were carried out as in section 2 
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inhibitor-l by insulin is likely to be important in the 
stimulation of glycogen synthesis by this hormone. 
We reported in [lo] that the degree of phosphoryla- 
tion of inhibitor-l in normal fed rabbits was 3 1 + 7%, 
and that it increased to 70 + 12% following an intra- 
venous administration of adrenaline, Since the levels 
of circulating insulin would be expected to be 
moderately high in the normal fed state, the values of 
28 + 11% and 40 rt 7% for the insulin and insulin + iso- 
proterenol experiments obtained in the present work 
with rat skeletal muscle are in good agreement with 
that data. 
Four interconvertible proteins which are regulated 
by cystosolic protein kinases and protein phosphatases 
have been shown to become dephosphorylated in vivo 
in response to insulin ,namely inhibitor-l and glycogen 
synthase ( 121 in skeletal muscle, and hydroxymethyl- 
glutaryl-CoA (HMG-CoA) reductase and HMG-CoA 
reductase kinase in hepatocytes [ 131. These observa- 
tions suggest hat a protein kinase becomes inhibited 
or a protein phosphatase becomes activated in 
response to insulin, and raises the possibility that 
many of the intracellular actions of this hormone 
take place through the same general mechanism. 
Glycogen synthase was the first enzyme which was 
shown to become dephosphorylated in response to 
insulin [ 121 and consequently this system has been 
the most intensively studied. However the regulation 
of this enzyme has turned out to be unexpectedly 
complex, since it can be p~iospho~lated and inactivated 
in vitro by at least three protein kinases (cyclic AMP- 
dependent protein kinase, phosphorylase kinase and 
glycogen synthase kinase3) which phosphorylate 
6 different serine residues [2,14,15]. These findings 
have raised the question of which glycogen synthase 
kinase might be under the control of insulin. The 
recent finding that insulin activates glycogen synthase 
in the soleus muscle of ICR,‘IAn mice which lack 
phosphorylase kinase [ 161, appears to eliminate this 
enzyme as the primary target for insulin action. 
Furthermore as phosphorylase kinase is completely 
dependent on Ca2” for activity and is the only Ca”- 
dependent protein involved in glycogen metabolism 
[I], the possibility that insulin stimulates glycogen 
synthesis by decreasing the [Ca”] in the muscle cyto- 
plasm appears to be excluded. 
The present finding that inhibitor-l is dephos- 
phorylated in response to insulin, simplifies the situa- 
tion considerably and narrows down the search for 
the target protein for insulin action. Inhibitor-l is 
not phosphorylated by either phosphorylase kinase 
or glycogen synthase kinase-3 [ 141 and no enzyme 
other than cyclic AMP-dependent protein kinase has 
been shown to phosphorylate this protein in vitro 
[5,8]. Insulin must therefore either inactivate cyclic 
AMP-dependent protein kinase or activate a protein 
phosphata~ which dephospho~lates ~hibitor-1 
in vivo . 
Incubation of rat henl~diaphragms with insulin 
does not cause any detectable decrease in the concen- 
tration of cyclic AMPunder conditions where glycogen 
synthase is activated (17,181. Similarly, no alteration 
in the concentration of cyclic AMP is observed in the 
rat hemicorpus system used here, when insulin is 
included in the perfusate (L.S.J., unpublished). If 
insulin inhibits the cyclic AMP-dependent protein 
kinase, it must therefore do so by a l~echanism 
unrelated to decreases in the concentration of cyclic 
AMP. 
A remarkable property of the protein phosphatase- 
l-inhibitor-l system is that inhibitor-l does not 
inhibit its own dephosphorylati~n, even at concen- 
trations 500..fold higher than those which inhibit the 
dephosphorylation of other substrates. Consequently, 
inhibitor-l is dephospllorylated by protein phospha- 
tase-1 with kinetic constants which are very similar to 
those observed for other substrates of the enzyme 
[ 1,8]. This property means that there is no need to 
invoke the existence of a separate phosphatase for 
the dephosp~lorylation of ~hibitor-1, and the state of 
phosphorylation of inhibitor-l may simply be a reflec- 
tion of the relative activities of cyclic UP-dependent 
protein kinase and protein phosphatase-1 [I]. 
The existence of other inhibitor-l phosphatases i  
not however excluded, and protein phosphatase-2 has 
also been shown to dephosphorylate inhibitor-l in vitro 
[8]. Protein phosphatase-2 isan enzyme which dephos- 
phorylates the o-subunit of phosphorylase kinase 
40-fold faster than the &subunit, in contrast to pro- 
tein phosphatase-1 which dephosphorylates the &sub- 
unit SO-fold faster than the a-subunit [ 1,191. Protein 
phosphatase-2 has lower phosphoryfase phosphatase 
and glycogen synthase phosphatase activity than pro- 
tein phosphatase-1 , and its activity is unaffected by 
inhibitor-l and inhibitor-2 [X9,20]. 
A low molecular weight substance in skeletal 
muscle has been partially purified whose concentration 
increased in response to insulin, and which inhibited 
cyclic AMP-dependent protein kinase in vitro [2 1,221. 
This fraction did not inhibit phosphoryla~ kinase or 
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two other cyclic AMP-independent glycogen synthase 
kinases tested 1221. However the same fraction acti- 
vated a crude preparation of glycogen synthase phos- 
phatase Z-fold [22]. These results are consistent with 
the conclusion drawn here; namely, that the primary 
site of insulin action is restricted to either cyclic AMP- 
dependent protein kinase and/or protein pllosphatase-1. 
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